Cargando…

Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence

BACKGROUND: Opioid agonist drugs produce analgesia. However, long-term exposure to opioid agonists may lead to opioid dependence. The analgesic and addictive properties of opioid agonist drugs are mediated primarily via the mu-opioid receptor (MOR). Opioid agonists appear to alter neuronal morpholog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Jay, Kittanakom, Saranya, Wong, Victoria, Reyes, Beverly AS, Van Bockstaele, Elisabeth J, Stagljar, Igor, Berrettini, Wade, Levenson, Robert
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841195/ https://www.ncbi.nlm.nih.gov/pubmed/20214800 http://dx.doi.org/10.1186/1471-2202-11-33

Ejemplares similares

Inhibition of Wntless/GPR177 suppresses gastric tumorigenesis
por: Seo, Jaesung, et al.
Publicado: (2018)

MOR Is Not Enough: Identification of Novel mu-Opioid Receptor Interacting Proteins Using Traditional and Modified Membrane Yeast Two-Hybrid Screens
por: Petko, Jessica, et al.
Publicado: (2013)

Alternative splicing of the Wnt trafficking protein, Wntless and its effects on protein-protein interactions
por: Petko, Jessica, et al.
Publicado: (2019)

The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis
por: Augustin, Iris, et al.
Publicado: (2012)

The role of Evi/Wntless in exporting Wnt proteins
por: Wolf, Lucie, et al.
Publicado: (2023)

SNX3 controls Wingless/Wnt secretion through regulating retromer-dependent recycling of Wntless
por: Zhang, Peng, et al.
Publicado: (2011)

The mu opioid receptor and the orphan receptor GPR151 contribute to social reward in the habenula
por: Allain, Florence, et al.
Publicado: (2022)

A SNX3-dependent Retromer pathway mediates retrograde transport of the Wnt sorting receptor Wntless and is required for Wnt secretion
por: Harterink, Martin, et al.
Publicado: (2011)

Split-Ubiquitin Based Membrane Yeast Two-Hybrid (MYTH) System: A Powerful Tool For Identifying Protein-Protein Interactions
por: Snider, Jamie, et al.
Publicado: (2010)

Cryo-EM structure of human Wntless in complex with Wnt3a
por: Zhong, Qing, et al.
Publicado: (2021)

A brief review of the genetics and pharmacogenetics of opioid use disorders
por: Berrettini, Wade
Publicado: (2017)

Gpr177 Deficiency Impairs Mammary Development and Prohibits Wnt-Induced Tumorigenesis
por: Maruyama, Eri Ohfuchi, et al.
Publicado: (2013)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Activity of opioid ligands in cells expressing cloned mu opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2003)

Mu Opioid Receptor Gene: New Point Mutations in Opioid Addicts
por: Dinarvand, Amin, et al.
Publicado: (2014)

Ligand-Directed Functional Selectivity at the Mu Opioid Receptor Revealed by Label-Free Integrative Pharmacology On-Target
por: Morse, Megan, et al.
Publicado: (2011)

Endogenous opioids: The downside of opposing stress
por: Valentino, Rita J., et al.
Publicado: (2014)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)

An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor Function
por: Rozenfeld, Raphael, et al.
Publicado: (2007)

Endogenous opioids: opposing stress with a cost
por: Valentino, Rita J., et al.
Publicado: (2015)

TMEM132A, a Novel Wnt Signaling Pathway Regulator Through Wntless (WLS) Interaction
por: Li, Binbin, et al.
Publicado: (2020)

WLS/wntless is essential in controlling dendritic cell homeostasis via a WNT signaling-independent mechanism
por: Wang, Li-Ting, et al.
Publicado: (2021)

SNX3-retromer requires an evolutionary conserved MON2:DOPEY2:ATP9A complex to mediate Wntless sorting and Wnt secretion
por: McGough, Ian J., et al.
Publicado: (2018)

Mu Opioid Receptor Actions in the Lateral Habenula
por: Margolis, Elyssa B., et al.
Publicado: (2016)

Comparison of physicochemical properties and biological activities of opioid morphinans interacting with mu opioid receptors
por: Asim, Muhammad F, et al.
Publicado: (2008)

Role of kappa‐opioid and mu‐opioid receptors in pruritus: Peripheral and central itch circuits
por: Kim, Brian S., et al.
Publicado: (2022)

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
por: Shen, Qianwei, et al.
Publicado: (2017)

Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D(2) Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
por: Vasudevan, Lakshmi, et al.
Publicado: (2019)

Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions
por: Liu, Shan, et al.
Publicado: (2021)

Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
por: Morse, Megan, et al.
Publicado: (2013)

Mu Opioid Splice Variant MOR-1K Contributes to the Development of Opioid-Induced Hyperalgesia
por: Oladosu, Folabomi A., et al.
Publicado: (2015)

Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation
por: Anantharamu, Tejus, et al.
Publicado: (2015)

Mu opioid receptors on vGluT2‐expressing glutamatergic neurons modulate opioid reward
por: Reeves, Kaitlin C., et al.
Publicado: (2020)

Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor
por: Smith, Mark A., et al.
Publicado: (2022)

Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu‐opioid receptor
por: Zhang, Jia‐Jia, et al.
Publicado: (2022)

Opioids, sleep, analgesia and respiratory depression: Their convergence on Mu (μ)-opioid receptors in the parabrachial area
por: Lynch, Nicole, et al.
Publicado: (2023)

Mu opioid receptor: from pain to glucose metabolism
por: Tudurí, Eva, et al.
Publicado: (2016)

A novel requirement for ubiquitin-conjugating enzyme UBC-13 in retrograde recycling of MIG-14/Wntless and Wnt signaling
por: Zhang, Junbing, et al.
Publicado: (2018)

Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade
por: Trøstheim, Martin, et al.
Publicado: (2022)

Endogenous Opioid Peptides and Alternatively Spliced Mu Opioid Receptor Seven Transmembrane Carboxyl-Terminal Variants
por: Abrimian, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mltst83rbr9n4b1h85rn8lf02d